10-Q: Ingredion Q2 Profit Soars on Lower Costs, EPS Up 35%
Quarterly Report
Ingredion Incorporated reported a significant increase in second-quarter net income and earnings per share, driven by lower raw material and input costs, despite a slight decline in net sales.
Summary
- Net income attributable to Ingredion increased 32.4% to $196 million for the second quarter of 2025, up from $148 million in the prior year.
- Diluted earnings per common share rose 34.7% to $2.99 in Q2 2025, compared to $2.22 in Q2 2024.
- Gross profit margin improved to 26% for Q2 2025, up from 24% in Q2 2024, primarily due to raw material and input costs declining faster than net sales.
- Net sales decreased 2% to $1,833 million for the second quarter of 2025, down from $1,878 million in Q2 2024, mainly due to price mix and lower volume in F&II segments.
- Operating income increased 12.9% to $271 million for Q2 2025, compared to $240 million in Q2 2024.
- Cash provided by operating activities for the six months ended June 30, 2025, was $262 million, a decrease from $521 million in the same period of 2024, primarily due to a $250 million change in working capital.
- The company increased its quarterly dividend to $0.80 per share in 2025 from $0.78 per share in 2024.
- Ingredion repurchased 409 thousand shares of common stock for $55 million year-to-date 2025, with 2.9 million shares remaining available under the repurchase program until December 31, 2025.
- A new joint venture with Agrana Strke GmbH was formed in June 2025, with Ingredion acquiring a 49% equity interest for $19 million to develop starch production in Romania.
Sentiment
Score: 8
Explanation: The filing indicates strong profitability and earnings growth driven by effective cost management and a favorable tax rate, despite a slight revenue decline. The company maintains robust liquidity and continues to return capital to shareholders through dividends and share repurchases. While cash flow from operations decreased due to working capital, the overall financial health and strategic positioning appear positive.
Positives
- Net income attributable to Ingredion increased significantly by 32.4% to $196 million for the second quarter of 2025.
- Diluted earnings per common share saw a substantial increase of 34.7% to $2.99 for Q2 2025.
- Gross profit margin improved by 2 percentage points to 26% in Q2 2025, indicating effective cost management relative to sales.
- Operating income grew by 12.9% to $271 million in Q2 2025, reflecting improved operational efficiency.
- The Texture & Healthful Solutions (T&HS) segment reported a 29% increase in adjusted operating income to $111 million, driven by lower raw material costs and higher volumes.
- The All Other segment significantly reduced its adjusted operating loss to $1 million from $10 million, primarily due to improvements in the plant-based protein business.
- Financing costs decreased by 28% year-to-date 2025 due to lower interest expense from reduced average outstanding debt balances.
- The effective income tax rate decreased to 23.6% in Q2 2025 from 34.8% in Q2 2024, contributing to higher net income.
- The company increased its quarterly dividend to $0.80 per share, demonstrating confidence in financial performance.
- Continued share repurchase program activity, with $55 million in repurchases year-to-date 2025, returning capital to shareholders.
Negatives
- Net sales decreased by 2% in Q2 2025 to $1,833 million, primarily due to price mix and lower volumes in the Food & Industrial Ingredients (F&II) segments.
- Cash provided by operating activities decreased significantly to $262 million year-to-date 2025 from $521 million year-to-date 2024, mainly due to a $250 million change in working capital from increased trade accounts receivables.
- Operating expenses increased by 9% to $208 million in Q2 2025, primarily due to increased employee costs.
- The F&II LATAM segment's adjusted operating income decreased by 2% to $127 million, negatively impacted by the floating exchange rate for the Argentine peso and related joint venture results.
- The F&II U.S./Canada segment's net sales decreased by 6% and adjusted operating income decreased by 18% to $86 million, primarily due to downtime from a mechanical fire and reduced industrial demand.
Risks
- Changes in consumer practices, preferences, demand, and perceptions may lessen demand for products.
- Geopolitical conflicts and actions arising from them, including impacts on raw material and energy availability and prices, supply chain interruptions, and volatility in foreign exchange and interest rates.
- Effects of global economic conditions and general political, economic, business, and market conditions that affect customers and consumers.
- Reliance on purchases of products by major industries served, such as food, beverage, animal nutrition, and brewing.
- Risks associated with pandemics.
- Ability to develop or acquire new products and services at rates or qualities sufficient to gain market acceptance.
- Increased competitive and/or customer pressure in the corn-refining industry and related industries, including the ability to pass through price increases in key inputs.
- Price fluctuations, supply chain disruptions, tariffs, duties, and shortages affecting inputs to procurement, production processes, and delivery channels.
- Ability to contain costs, achieve budgets, and realize expected synergies, including managing planned maintenance, investment projects, freight, shipping, and hedging activities.
- Operating difficulties at manufacturing facilities and liabilities relating to product safety and quality.
- Effects of climate change and legal, regulatory, and market measures to address climate change.
- Ability to successfully identify and complete acquisitions, divestitures, or strategic alliances on favorable terms, and to integrate acquired businesses or implement alliances.
- Economic, political, and other risks inherent in conducting operations in foreign countries and in foreign currencies.
- Failure to maintain satisfactory labor relations and ability to attract, develop, motivate, and maintain good relationships with the workforce.
- Impact of legal and regulatory proceedings, lawsuits, claims, and investigations.
- Impact of any impairment charges on goodwill or long-lived assets.
- Impact on business of political events, trade and international disputes, war, threats or acts of terrorism, and natural disasters.
- Changes in government policy, law, or regulation and costs of legal compliance, including environmental regulation.
- Changes in tax rates or exposure to additional income tax liability.
- Risks affecting ability to raise funds at reasonable rates and other factors affecting access to sufficient funds for future growth and expansion.
- Increases in interest rates that could increase borrowing costs.
- Interruptions, security incidents, or failures with respect to information technology systems, processes, and sites.
- Risks affecting the continuation of the dividend policy.
- Ability to maintain effective internal control over financial reporting.
Future Outlook
The company anticipates capital investment commitments for the full year of 2025 to be between $400 million and $425 million. It expects available cash balances, future cash flow from operations, and access to debt markets to provide sufficient liquidity for anticipated capital expenditures, dividends, and other operating, investing, and financing activities for at least the next twelve months and the foreseeable future. The company is currently evaluating the impact of the recently enacted U.S. One Big Beautiful Bill Act (OBBBA) on its consolidated financial statements.
Management Comments
- Net income attributable to Ingredion for year-to-date 2025 increased to $393 million from $364 million for year-to-date 2024. Excluding the $82 million pre-tax gain from the sale of our South Korea business in February 2024, the net income increase was primarily due to a 21 percent increase in operating income to $547 million for year-to-date 2025 from $453 million for year-to-date 2024, which was driven by corn and input costs declining faster than the decrease in net sales.
- We continue to monitor changing tariff requirements and reciprocal actions, as well as indirect effects in the economic environment, which may adversely affect our operations, although these factors have had an immaterial impact on our results for year-to-date 2025.
- We believe that our consolidated subsidiaries will be able to meet their financial obligations as they become due.
- We currently expect that our available cash balances, future cash flow from operations, access to debt markets and borrowing capacity under our revolving credit facility and commercial paper program will provide us with sufficient liquidity to fund our anticipated capital expenditures, dividends and other operating, investing and financing activities for at least the next twelve months and for the foreseeable future thereafter.
- We do not anticipate the need to repatriate funds to the U.S. to satisfy domestic liquidity needs arising in the ordinary course of business, including liquidity needs associated with our domestic debt service requirements.
Industry Context
Ingredion operates in the global ingredients solutions market, transforming plant-based materials into value-added ingredients for diverse industries including food, beverage, animal nutrition, and industrial markets. The company's performance reflects broader industry trends where managing raw material costs is crucial, especially as input costs decline. While net sales saw a slight decrease, the ability to improve gross profit margins by having input costs decline faster than sales indicates strong cost management in a potentially deflationary raw material environment. The investment in a new starch production joint venture in Romania aligns with the ongoing demand for specialized food ingredients and expansion into new markets. The challenges faced by the F&II U.S./Canada segment due to a mechanical fire and reduced industrial demand highlight the sensitivity of the industrial ingredients sector to operational disruptions and economic cycles.
Comparison to Industry Standards
- The significant improvement in gross profit margin (26% in Q2 2025 vs. 24% in Q2 2024) suggests effective cost management, potentially outperforming peers who may struggle to capture similar benefits from declining raw material costs.
- The 34.7% increase in diluted EPS for Q2 2025, despite a 2% decline in net sales, indicates strong profitability leverage, which could position Ingredion favorably against competitors focused solely on top-line growth.
- The decrease in cash provided by operating activities due to working capital changes (specifically increased trade accounts receivables) warrants attention, as efficient working capital management is a key industry benchmark for operational excellence. This could be an area where the company lags behind best-in-class peers who optimize cash conversion cycles.
- The investment in the Agrana joint venture for starch production in Romania aligns with industry trends of expanding into high-growth regions and diversifying product portfolios, similar to strategic moves by global ingredient players like ADM or Cargill, though specific project-level comparisons are not provided in the filing.
Legal Proceedings
- No material developments in the environmental proceedings related to the Bedford Park, Illinois manufacturing facility.
- The company is subject to claims and suits arising in the ordinary course of business, including labor matters, environmental proceedings, and commercial claims.
- Routinely receives inquiries from regulators and other government authorities regarding various aspects of the business, including environmental compliance.
Related Party Transactions
- The company holds a 49% joint venture equity ownership in Ingrear Holding S.A. (Argentina joint venture), accounted for under the equity method.
- Entered into a joint venture agreement with Agrana Strke GmbH (Agrana joint venture) in June 2025, acquiring a 49% equity interest for $19 million, also accounted for under the equity method.
Stakeholder Impact
- Shareholders benefit from increased net income, higher diluted EPS, an improved gross profit margin, and an increased quarterly dividend of $0.80 per share.
- Shareholders also benefit from the ongoing stock repurchase program, which reduces outstanding shares and returns capital.
- Employees are impacted by increased employee costs, contributing to higher operating expenses.
- Customers may benefit from lower raw material costs, which contributed to a decrease in net sales due to price mix.
- Creditors are impacted by stable total debt outstanding and a slightly lower weighted average interest rate on indebtedness.
- Suppliers are engaged through supply chain finance programs, allowing them to sell receivables to third-party banks for earlier payment.
Next Steps
- The company will continue to evaluate the impact of the U.S. One Big Beautiful Bill Act (OBBBA) on its consolidated financial statements.
- Anticipated cash contributions of $1 million to U.S. pension plans and $2 million to non-U.S. pension plans in 2025.
- Capital investment commitments for the full year of 2025 are anticipated to be between $400 million and $425 million.
- The company expects to receive remaining consideration from the South Korea business divestiture in equal annual payments through February 2027.
- The Agrana joint venture will recognize its share of net income one month in arrears in the Texture & Healthful Solutions segment.
- The stock repurchase program is authorized until December 31, 2025, with 2.9 million shares available for repurchase.
- Management's Rule 10b5-1(c) stock sale plans commenced on August 6, 2025, with varying expiration dates (May 7, 2026, and December 31, 2027).
Key Dates
| Date | Description |
|---|---|
| December 31, 2023 | Balance sheet date for prior year comparison. |
| February 1, 2024 | Completion date of the sale of the South Korea business. |
| March 31, 2024 | Balance sheet date for prior year comparison. |
| June 30, 2024 | End of prior year's second fiscal quarter and six-month period. |
| December 31, 2024 | Balance sheet date for prior year comparison and end of prior fiscal year. |
| January 1, 2025 | Effective date for the adoption of ASU No. 2023-05, Business Combinations Joint Venture Formations, and effective date for resegmentation. |
| February 2025 | Vesting of 2022 performance share awards at 200% payout. |
| May 7, 2025 | Date James P. Zallie and Larry Fernandes entered into Rule 10b5-1(c) stock sale plans. |
| June 2025 | Company entered into a joint venture agreement with Agrana Strke GmbH (Agrana joint venture). |
| June 30, 2025 | End of current second fiscal quarter and six-month period. |
| July 4, 2025 | U.S. enacted the One Big Beautiful Bill Act (OBBBA), introducing tax reforms. |
| August 6, 2025 | Commencement date for James P. Zallie's and Larry Fernandes' Rule 10b5-1(c) stock sale plans. |
| August 7, 2025 | Latest practicable date for common stock outstanding shares (64,180,890 shares). |
| August 11, 2025 | Date of filing of the Form 10-Q. |
| October 1, 2026 | Maturity date for 3.200% senior notes. |
| December 15, 2024 | Effective date for annual periods beginning after for ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. |
| December 15, 2026 | Effective date for annual periods beginning after for ASU No. 2024-03, Income Statement Reporting Comprehensive Income Expense Disaggregation Disclosure (Subtopic 220-40). |
| December 31, 2025 | Expiration date of the stock repurchase program and expiration date for James P. Zallie's Rule 10b5-1(c) stock sale plan (if shares not sold earlier). |
| February 2027 | Final payment for the South Korea business divestiture is expected by this date. |
| April 15, 2037 | Maturity date for 6.625% senior notes. |
| June 1, 2030 | Maturity date for 2.900% senior notes. |
| June 1, 2050 | Maturity date for 3.900% senior notes. |
| May 7, 2026 | Expiration date for Larry Fernandes' Rule 10b5-1(c) stock sale plan (if shares not sold earlier). |
| December 31, 2027 | Expiration date for James P. Zallie's Rule 10b5-1(c) stock sale plan (if shares not sold earlier). |
Recommendation
buyThe filing demonstrates strong underlying profitability and operational efficiency, with significant increases in net income and EPS despite a slight decline in sales. This indicates effective cost management and margin expansion. The company maintains robust liquidity, is actively returning capital to shareholders through dividends and share repurchases, and is strategically investing in growth areas like the new joint venture. While cash flow from operations saw a temporary dip due to working capital, the overall financial health and strategic direction are positive, suggesting potential for continued value creation.
Keywords
Ingredients, Food & Beverage, Starches, Sweeteners, Plant-based ingredients, Nutrition, Corn refining, Specialty ingredients, Financial results, SEC filing, Quarterly report
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.